Not finding it? Sign in to also search OpenAlex live.
-
Benefit‐Risk Assessment of Off‐Label Drug Use in Children: The Bravo Framework2021 Clinical Pharmacology & Therapeutics article Medicine Pharmaceutical studies and practices Open access
Tjitske M. van der Zanden, Miriam G. Mooij, Nienke J. Vet, Antje C. Neubert, Wolfgang Rascher, Florian B. Lagler, +5 more
63citations -
Abstract PD15-04: Breast Cancer Index and assessment of the Net Treatment Benefit (NTB) of extended endocrine therapy in HR+ breast cancer2022 Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Marc E Buyse, Jenna Wong, Samuel Salvaggio, Jean‐Christophe Chiêm, Yi Zhang, Kai Treuner, +4 more
0citations -
OC03.01: *A comparison between the IOTA assessment of different neoplasias in the adnexa, the risk of malignancy index and the risk of ovarian malignancy algorithm to assess the risk of malignancy in women with an ovarian tumour2020 Ultrasound in Obstetrics and Gynecology conference-abstract Medicine Ovarian cancer diagnosis and treatment Open access
Chiara Landolfo, Jolien Ceusters, An Coosemans, Toon Van Gorp, Wouter Froyman, Ruben Heremans, +10 more
0citations -
Cardiac MRI-Guided Assessment of Defibrillator Benefit in Cardiac Resynchronization Therapy for Non-Ischemic Cardiomyopathy2026 Journal of Cardiovascular Magnetic Resonance article Medicine Cardiac pacing and defibrillation studies Open access
Anna Charlotte Tuinman, Luuk H G A Hopman, Sophie van der Geest, Philippe J. van Rosendael, Marco Götte, Vokko P. van Halm, +1 more
0citations -
How to Interpret an Investigator’s Brochure for Meaningful Risk Assessment: Results of an AGAH Discussion Forum2021 Therapeutic Innovation & Regulatory Science article Medicine Ethics in Clinical Research Open access
Jens Rengelshausen, Kerstin Breithaupt-Groegler, Frank Donath, Katharina Erb‐Zohar, Timothy Colin Hardman, Gerd Mikus, +3 more
27citations -
Multiple Perspectives on the Need for Real‐World Evidence to Inform Regulatory and Health Technology Assessment Decision‐Making: Scoping Review and Stakeholder Interviews2025 Pharmacoepidemiology and Drug Safety article Economics, Econometrics and Finance Health Systems, Economic Evaluations, Quality of Life Open access
Marieke S. Jansen, Olaf M. Dekkers, Saskia le Cessie, Lotty Hooft, Helga Gardarsdóttir, Anthonius de Boer, +1 more
6citations -
Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation (PERSPECTIVE I&I)2021 Journal of Personalized Medicine article Medicine Global Cancer Incidence and Screening Open access
Jennifer D. Brooks, Hermann Nabi, Irene Louise Andrulis, Antonis C. Antoniou, Jocelyne Chiquette, Philippe Després, +23 more
122citations -
Evaluation approach to assess actions and scenarios for improving climate and resource efficiency of municipalities and companies in industrial parks2025 Journal of Environmental Management article Engineering Sustainable Industrial Ecology Open access
Benedikt Verkic, Kornelia Theodora Drees, Klaus Dosch, Christian Buschbeck, Kathrin Greiff
2citations -
Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment2020 Vaccine article Biochemistry, Genetics and Molecular Biology Virus-based gene therapy research Open access cited by 2 patents
Jerome H. H. V. Custers, Denny Kim, Maarten Leyssen, Marc Gurwith, Frank L. Tomaka, James S. Robertson, +10 more
84citations -
HTA366 Challenges and Criteria for Accepting Lower-Level of Evidence in Early Benefit Assessments (EBA) in Germany2024 Value in Health conference-abstract Economics, Econometrics and Finance Health Systems, Economic Evaluations, Quality of Life Open access
Jörg Tomeczkowski, K Herrmann, Birte Eichinger, Friedhelm Leverkus, Ulrike Osowski, CM Dintsios, +4 more
0citations -
Early [18F]FDG PET/CT response evaluation after a single dose of anti-EGFR therapy as a predictive biomarker for treatment benefit in patients with advanced colorectal cancer.2024 Journal of Clinical Oncology conference-abstract Medicine Colorectal Cancer Treatments and Studies
Catharina Wilhelmina Menke, Sophie L. Gerritse, Erik Jacobus Van Helden, Anne I.J. Arens, Ronald Boellaard, Tineke E. Buffart, +8 more
0citations -
Modifiable risk factors and motivation for lifestyle change of CVD patients starting cardiac rehabilitation: The BENEFIT study2025 Research portal (Tilburg University) dataset Medicine Cardiac Health and Mental Health Open access
Linda D. Breeman, Roderik A. Kraaijenhagen, Katherine Wolstencroft, Douwe E. Atsma, Niels Henrik Chavannes, Hareld Kemps, +2 more
0citations -
Critical appraisal of combination therapies: the impact of trial design on Benefit-Risk outcomes2026 JNCI Journal of the National Cancer Institute article Mathematics Statistical Methods in Clinical Trials
Floor de Jong, Li-Anne H Douma, Paul Baas, Cornedine Jannette de Gooijer, Hans A. J. Gelderblom, Jacobus A. Burgers, +1 more
0citations